Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma × Axitinib × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 5 Neoplasms 1 Carcinoma 1

Interventions

Sorafenib 2 temsirolimus 1 niraparib 1 gadolinium ethoxybenzyl DTPA 1 donafenib 1 Transurethral Resection of Prostate 1 Therapeutics 1 Sunitinib 1 Phlebotomy 1 Palliative Care 1 Mitomycin 1 Maintenance 1 Interviews as Topic 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hepatectomy 1 Fatty Acids, Omega-6 1 Endoscopy 1 Cetuximab 1 Blood Specimen Collection 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Pfizer

684 enrolled 20 charts

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡